The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

 


Comments


View Comments / Leave a Comment

This post currently has 0 comments.
You can read the comments or leave your own thoughts.


    Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
    Published on PsychCentral.com. All rights reserved.

APA Reference
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on September 30, 2014, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/

 

Recent Comments
  • Momma: I wish my daughter could read this because she thinks because she wasn’t raised with money to spare we...
  • Drug Rehab Agency: Well, to be honest, I can see why you are upset with the tactic. However, as Curt noted, not all...
  • kalton: “They miss deadlines at work or call in sick often.” WRONG. The vast majority of “high...
  • Kat: I’m questioning how some of Cantor’s studies were designed. For example, I’m wondering where...
  • Minxlpn: Thank you and god bless you!
Subscribe to Our Weekly Newsletter


Find a Therapist
Enter ZIP or postal code